COST-EFFECTIVENESS OF TOCILIZUMAB FOR THE TREATMENT OF ACTIVE RHEUMATOID ARTHRITIS (RA) PATIENTS WITH INADEQUATE RESPONSE TO ANTI-TNF TREATMENT IN TURKEY

被引：1
|
作者：
Ertenli, I [1 ]
机构：
[1] Hacettepe Univ, Fac Med, TR-06100 Ankara, Turkey
来源：
VALUE IN HEALTH | 2012年 / 15卷 / 07期
关键词：
D O I：
10.1016/j.jval.2012.08.1390
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A445 / A445
页数：1
相关论文
共 50 条
  • [41] POWER DOPPLER ULTRASOUND MONITORING OF RESPONSE TO ANTI-TNFα TREATMENT IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Iagnocco, A.
    Ceccarelli, F.
    Perricone, C.
    Finucci, A.
    Gattamelata, A.
    Iorgoveanu, V.
    Valesini, G.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 1113 - 1114
  • [42] THE COST-EFFECTIVENESS OF ABATACEPT IN COMBINATION WITH METHOTREXATE FOR THE TREATMENT OF PATIENT WITH ACTIVE RHEUMATOID ARTHRITIS AFTER AN INADEQUATE RESPONSE TO METHOTREXATE IN THE UNITED KINGDOM
    Lebmeier, M.
    Pericleous, L.
    Drost, P.
    Dequen, P.
    Ouwens, M.
    Bergman, G.
    Baig, H.
    [J]. VALUE IN HEALTH, 2010, 13 (07) : A309 - A309
  • [43] COST-EFFECTIVENESS OF USE OF ETANERCEPT VS THE ANTI-TNF MONOCLONAL ANTIBODY IN PATIENTS WITH RHEUMATOID ARTHRITIS IN COSTA RICA
    Aguirre, A.
    Garcia, E.
    Bierschwale, H.
    Prado, M.
    [J]. VALUE IN HEALTH, 2009, 12 (07) : A522 - A522
  • [44] COST-EFFECTIVENESS OF TOCILIZUMAB MONOTHERAPY VERSUS ADALIMUMAB MONOTHERAPY IN THE TREATMENT OF SEVERE ACTIVE RA
    Carlson, J. J.
    Ogale, S.
    Dejonckheere, F.
    Sullivan, S. D.
    [J]. VALUE IN HEALTH, 2012, 15 (07) : A447 - A447
  • [45] Serious infections during anti-TNFα treatment in rheumatoid arthritis patients
    Favalli, Ennio Giulio
    Desiati, Francesca
    Atzeni, Fabiola
    Sarzi-Puttini, Piercarlo
    Caporali, Roberto
    Pallavicini, Francesca Bobbio
    Gorla, Roberto
    Filippini, Matteo
    Marchesoni, Antonio
    [J]. AUTOIMMUNITY REVIEWS, 2009, 8 (03) : 266 - 273
  • [46] THE STEROID SPARING EFFECT OF ANTI-TNF TREATMENT IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Smith, Laura-Jane
    Reade, Helen C.
    Sheehan, Nicholas J.
    Dahiya, Sandeep
    [J]. RHEUMATOLOGY, 2009, 48 : I66 - I67
  • [47] Predictors of neutropaenia on anti-TNF treatment for rheumatoid arthritis
    Rajakulendran, S.
    Gadsby, K.
    Allen, D.
    O'Reilly, S.
    Deighton, C.
    [J]. RHEUMATOLOGY, 2006, 45 : I48 - I49
  • [48] The safety of abatacept in patients with active rheumatoid arthritis and an inadequate response to anti-TNF therapy: Results from the arrive trial
    Schiff, M.
    Pritchard, C.
    Teng, J.
    Bahrt, K.
    Genovese, M.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 89 - 89
  • [49] Abatacept has beneficial effects in rheumatoid arthritis patients with an inadequate response to anti-TNFα therapy
    Genovese, MC
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2005, 23 (06) : 767 - 768
  • [50] Cost-Effectiveness of Tocilizumab Monotherapy Vs. Adalimumab Monotherapy in the Treatment of Severe Active Rheumatoid Arthritis.
    Carlson, Josh J.
    Ogale, Sarika
    Dejonckheere, Fred
    Sullivan, Sean
    [J]. ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S1037 - S1038
12345